#30 – Is More Better? The Role of Combination Therapy for MRSA episode artwork

EPISODE · Oct 9, 2020 · 1H 1M

#30 – Is More Better? The Role of Combination Therapy for MRSA

from Breakpoints

Host Erin McCreary (@erinmccreary) and expert panelists Dr. Katie Barber (@IDKatieBarb), Dr. Warren Rose (@Warren_E_Rose), and Dr. Steven Tong (@syctong) discuss data from early laboratory work to randomized, clinical trials for various antibiotic combinations used in the treatment of MRSA bacteremia. This was our most requested topic to cover on Breakpoints, and we hope you enjoy! Please complete this brief survey to help us continue to improve Breakpoints content: https://docs.google.com/forms/d/e/1FAIpQLSeriW-TAgiBik2_gdJllCZ4WqADhUyFIZtTAgYAYxRU5YU3hA/viewform?vc=0&c=0&w=1&flr=0 Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx LinkedIn: https://www.linkedin.com/company/sidp/

Episode metadata supplied by the publisher feed · Published Oct 9, 2020

Embed this episode

Ready to play

#30 – Is More Better? The Role of Combination Therapy for MRSA

0:00 1:01:44

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Breakpoints?

This episode is 1 hour and 1 minute long.

When was this Breakpoints episode published?

This episode was published on October 9, 2020.

Can I download this Breakpoints episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!